dihydromevinolin

dihydromevinolin Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

White to Off-White Solid

Verwenden

4a,5-Dihydro Lovastatin is an impurity in Lovastatin (L472225) bulk drug.

dihydromevinolin Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

dihydromevinolin Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Hubei Jusheng Technology Co.,Ltd.	18871490254	linda@hubeijusheng.com	CHINA	28172	58
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14332	58
Career Henan Chemica Co	+86-0371-86658258 +8613203830695	laboratory@coreychem.com	China	30239	58
BOC Sciences	16314854226; +16314854226	inquiry@bocsci.com	United States	19741	58
Aladdin Scientific	+1-+1(833)-552-7181	sales@aladdinsci.com	United States	57505	58
Moxin Chemicals	+8617320513646	mike@molcoo.com	China	9460	58
Guangzhou PI PI Biotech Inc	020-81716320 +86-13602409664	Sales@pipitech.com	China	3633	55
J & K SCIENTIFIC LTD.	010-82848833 400-666-7788	jkinfo@jkchemical.com	China	96815	76
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32321	50
Sinopharm Chemical Reagent Co,Ltd.	86-21-63210123	sj_scrc@sinopharm.com	China	9815	79

---

• dihydromevinolin
• (S)-2-Methylbutyric acid [(1S)-1,2,3,4,4a,7,8,8aα-octahydro-3β,7α-dimethyl-8α-[2-[[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran]-2-yl]ethyl]naphthalen]-1β-yl ester
• dihydro-lovastatin
• Lovastatin Related CoMpound A
• Lovastatin EP IMpurity E
• Lovastatin Related Compound A (20 mg) (Dihydro-lovastatin)
• (2S)-2-Methylbutanoic Acid (1S,3S,4aR,7S,8S,8aS)-1,2,3,4,4a,7,8,8a-Octahydro- 3,7-diMethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester
• 4a,5-Dihydro Lovastatin
• L 154883
• MSD 883
• Butanoic acid, 2-methyl-, 1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha (R*), 3-alpha, 4a-alpha, 7-beta, 8-beta (2S*
• Lovastatin Impurity 5(Lovastatin EP Impurity E)
• (S)-(1S,3S,4aR,7S,8S,8aS)-8-(2-((2R,4R)
• (1S,3S,4aR,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxotetrahydro-2H- pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,4,4a,7,8,8a-octahydro-1-naph thalenyl (2S)-2-methylbutanoate
• Butanoic acid, 2-methyl-, (1S,3S,4aR,7S,8S,8aS)-1,2,3,4,4a,7,8,8a-octahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-
• (S)-(1S,3S,4aR,7S,8S,8aS)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl 2-methylbutanoate (Lovastatin Impurity)
• 77517-29-4
• Chiral Reagents
• Heterocycles
• Impurities
• Intermediates & Fine Chemicals
• Pharmaceuticals